← Leaderboards
Jonathan Feldschuh
Daxor Corporation
$817,324
Attributed
$817,324
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $457.3K · FY2021–23$500K$375K$250K$125K$0
'21
'22
'23
Funding mix
By agency
NIH$817,324 · 2
By mechanism
R43$817,324 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Hospitalization”
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Ted Ross · University Of Georgia$68,763,143
- Abraham Aizer Brody · New York University School Of Medicine$40,089,349
- Xinhua Li · Nano Terra, Inc.$32,991,103
- James Dale Berry · Brigham And Women'S Hospital$20,824,388
- Tareq Al Baghdadi · Saint Joseph Mercy Health System$19,225,531
Research focus
HospitalizationPositioning AttributeDiagnosticGuidelinesMaltreatmentMethodologyCostDiagnosisDilution TechniquesEvaluationHospitalsIatrogenesisAffectMeasurementCommercial ApplicationBlood Plasma VolumeDesignBlood VolumeAmericanCessation Of LifeErythrocytesCaringCell VolumesProspective
Grant awards (4)
Precision Guidance of Resuscitation and Deresuscitation in Sepsis$305,000
R43 · FY2023 · GM · contact PI
Development and validation of precision blood volume diagnostic and decision support device for acute decompensated heart failure$55,000
R43 · FY2022 · HL · contact PI
Development and validation of precision blood volume diagnostic and decision support device for acute decompensated heart failure$299,999
R43 · FY2021 · HL · contact PI
Development and validation of precision blood volume diagnostic and decision support device for acute decompensated heart failure$157,325
R43 · FY2021 · HL · contact PI